Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin effects on longevity genes in prediabetes
NCT01765946Phase 4Completed
- Sponsor
- Università di Padova
- Start
- Jun 2010
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in prediabetes comparing Metformin with Placebo (2 arms). Primary endpoint: Expression of longevity genes SIRT1, p66Shc, p53 and mTOR in PBMCs at 2 months. Started Jun 2010; status: completed.
02
Drugs
metformin
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT01765946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01765946.